| Serial Number | 98164705 |
| Word Mark | CRISPR THERAPEUTICS |
| Filing Date | Tuesday, September 5, 2023 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Wednesday, August 7, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Education services, namely, providing online non-downloadable articles and newsletters in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy |
| Description of Mark | The mark consists of an incomplete square with a break in the lower right of the square. At the bottom of the square below the break appears a shaded rectangle. In the lower middle of the square appears the stylized word "CRISPR", with the second "R" connected to the square. In the shaded rectangle appears the stylized word "THERAPEUTICS". |
| Goods and Services | Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections and inflammatory disease; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections and inflammatory disease; pharmaceutical products and preparations, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| NOT AVAILABLE | THERAPEUTICS |
| Goods and Services | Scientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development, namely, providing medical and scientific research and development in the fields of pharmaceuticals and biopharmaceuticals; medical research laboratory services; scientific laboratory services; custom cell-line engineering services for scientific research purposes; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to individuals |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 28, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | Monday, July 22, 2019 |
| First Use In Commerce Date | Monday, July 22, 2019 |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 28, 2023 |
| Primary Code | 041 |
| First Use Anywhere Date | Thursday, October 31, 2013 |
| First Use In Commerce Date | Thursday, October 31, 2013 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 28, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Thursday, October 31, 2013 |
| First Use In Commerce Date | Thursday, October 31, 2013 |
| Party Name | CRISPR Therapeutics AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | ZUG V8 6300 CH |
| Event Date | Event Description |
| Friday, September 8, 2023 | NEW APPLICATION ENTERED |
| Thursday, September 28, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, September 29, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Friday, May 10, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, May 10, 2024 | NON-FINAL ACTION E-MAILED |
| Friday, May 10, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, May 1, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, August 7, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, August 7, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, August 7, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |